Clinical Lung Cancer

1

Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years

Laurie E. Gaspar, Erica J. McNamara, E. Greer Gay, Joe B. Putnam, Jeffrey Crawford, Roy S. Herbst, James A. Bonner

Journal:

Year:

2012

Language:

english

File:

PDF, 305 KB

english, 2012

2

Fibroblast Growth Factor Signaling in Non–Small-Cell Lung Cancer

Thomas J. Semrad, Philip C. Mack

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 561 KB

english, 2012

3

Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-Analysis

Jingbo Wang, Kathy Welch, Luhua Wang, Feng-Ming (Spring) Kong

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 460 KB

english, 2012

4

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

Athanasios G. Pallis, Alexandra Voutsina, Nikolaos Kentepozidis, Stylianos Giassas, Pavlos Papakotoulas, Sofia Agelaki, Kostas Tryfonidis, Athanasios Kotsakis, Lambros Vamvakas, Nikolaos Vardakis, Vas

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 374 KB

english, 2012

5

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, Sandro Barni

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 473 KB

english, 2012

6

Safety Profile and Tolerability of Antiangiogenic Agents in Non–Small-Cell Lung Cancer

Shirish M. Gadgeel

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 424 KB

english, 2012

7

Successful Long-Term Treatment With Pemetrexed of NSCLC Associated With EML4-ALK and Low Thymidylate Synthase Expression

Masayuki Takeda, Isamu Okamoto, Kazuko Sakai, Kaoru Tanaka, Masaaki Terashima, Kazuto Nishio, Kazuhiko Nakagawa

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 762 KB

english, 2012

8

The Relationship Between Chronic Obstructive Pulmonary Disease and Lung Cancer in African American Patients

Nader Mina, Ayman O. Soubani, Michele L. Cote, Tariq Suwan, Angie S. Wenzlaff, Sunil Jhajhria, Husam Samarah, Ann G. Schwartz

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 301 KB

english, 2012

9

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

Ezra E.W. Cohen, Janakiraman Subramanian, Feng Gao, Livia Szeto, Mark Kozloff, Leonardo Faoro, Theodore Karrison, Ravi Salgia, Ramaswamy Govindan, Everett E. Vokes

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 336 KB

english, 2012

10

Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan

Shih-Wei Lai, Kuan-Fu Liao, Pei-Chun Chen, Pang-Yao Tsai, Dennis Paul Hsientang Hsieh, Ching-Chu Chen

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 262 KB

english, 2012

11

Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer

Makoto Nakagawa, Hidetaka Uramoto, Soichi Oka, Yasuhiro Chikaishi, Takashi Iwanami, Hidehiko Shimokawa, Tomoko So, Takeshi Hanagiri, Fumihiro Tanaka

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 332 KB

english, 2012

12

Correction

Journal:

Clinical Lung Cancer

Year:

2012

File:

PDF, 53 KB

2012

13

Correction

Journal:

Clinical Lung Cancer

Year:

2012

File:

PDF, 53 KB

2012

14

Editorial Board

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 62 KB

english, 2012

15

Volume 13; Issue 2

Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years

Fibroblast Growth Factor Signaling in Non–Small-Cell Lung Cancer

Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-Analysis

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer: A Meta-Analysis of 13 Randomized Trials

Safety Profile and Tolerability of Antiangiogenic Agents in Non–Small-Cell Lung Cancer

Successful Long-Term Treatment With Pemetrexed of NSCLC Associated With EML4-ALK and Low Thymidylate Synthase Expression

The Relationship Between Chronic Obstructive Pulmonary Disease and Lung Cancer in African American Patients

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan

Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer

Correction

Correction

Editorial Board

Table of Contents